跳至主要内容
临床试验/CTRI/2021/01/030500
CTRI/2021/01/030500尚未招募Phase 3 4

Comparative study between Tramadol and Butorphanol as an adjuvant to Bupivacaine for supraclavicular brachial plexus block.

Self1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年1月21日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
To study the onset and duration of sensory and motor blockade.

研究概览

简要总结

Brachial plexus block is widely used as an alternative to general anesthesia for upper limb surgeries. In this study, one group will receive Tramadol with Bupivacaine and the second group will receive Butorphanol with Bupivacaine. Both groups will be compared on the basis of onset and duration of motor and sensory block, duration of post operative analgesia, requirements of rescue analgesia and drug related adverse effects.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • ASA-PS I and II patients posted for upper limb orthopedic surgeries under Supraclavicular brachial plexus block.

排除标准

  • Patient refusal, Morbidly obese patients (body mass index >35 kg/m2), Pregnant or lactating women, Allergy or addiction to study drugs, Patients receiving chronic analgesic therapy, Coagulopathies, and Pre-existing peripheral neuropathy.

结局指标

主要结局

To study the onset and duration of sensory and motor blockade.

时间窗: 1.5 years

次要结局

  • To study duration of postoperative analgesia, requirements of rescue analgesia, and drug-related adverse effects in Supraclavicular Brachial plexus block.(1.5 years)

研究者

发起方
Self
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验